Screener
Acadia Pharmaceuticals ACAD PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Inventory | 32,372 | 34,670 |
| Prepaid expenses and other current assets | 69,369 | 59,526 |
| Total current assets | 1,224,545 | 1,062,113 |
| Property and equipment, net | 17,107 | 7,511 |
| Operating lease right-of-use assets | 69,424 | 47,354 |
| Intangible assets, net | 103,448 | 108,893 |
| Restricted cash | 7,846 | 7,845 |
| Long-term inventory | 76,301 | 76,704 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Acadia Pharmaceuticals's PP&E (net)?
- Acadia Pharmaceuticals (ACAD) reported PP&E (net) of $17.11M in Q2 2026.
- How has Acadia Pharmaceuticals's PP&E (net) changed year-over-year?
- Acadia Pharmaceuticals's PP&E (net) increased by 382.3% year-over-year, from $3.55M to $17.11M.
- What is the long-term trend for Acadia Pharmaceuticals's PP&E (net)?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's PP&E (net) has grown at a -3.9% compound annual growth rate (CAGR), from $9.16M to $7.51M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Acadia Pharmaceuticals's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude